Results 201 to 210 of about 1,254,005 (293)

Light Environment Control to Enhance Recombinant Protein Yield Per Unit Area With Dense Nicotiana benthamiana Canopy in a Transient Gene Expression System

open access: yesBiotechnology and Bioengineering, EarlyView.
ABSTRACT Transient expression systems enable rapid and scalable production of plant‐made pharmaceuticals (PMPs). However, maximizing PMP productivity while optimizing electricity use on vertical farms remains challenging. Increasing planting density improves biomass per area but can reduce PMP content per biomass due to self‐shading.
Ji‐Yoon Lee   +2 more
wiley   +1 more source

Longitudinal methylation analysis for risk stratification of CIN2 lesions by HPV genotype. [PDF]

open access: yesActa Obstet Gynecol Scand
Pikkujämsä H   +9 more
europepmc   +1 more source

Mechanistic Digital Model for Real‐Time Monitoring and Optimization of Adenovirus Production

open access: yesBiotechnology and Bioengineering, EarlyView.
ABSTRACT Adenoviral vectors are a critical vaccine platform, with billions of vaccine doses administered during the COVID‐19 pandemic. In addition, they are promising therapeutics for cancer treatment. To advance their manufacturing, real‐time monitoring of adenovirus production is essential for process optimization, yield improvement, and product ...
Xingge Xu   +4 more
wiley   +1 more source

Evaluation of the immunogenic properties of a chimeric protein against West Nile virus: in-silico analysis and assessment in mouse. [PDF]

open access: yesIran J Microbiol
Arezoumandi M   +7 more
europepmc   +1 more source

Early protection events in swine immunized with an experimental live attenuated classical swine fever marker vaccine, FlagT4G. [PDF]

open access: yesPLoS One, 2017
Holinka LG   +9 more
europepmc   +1 more source

Cryo‐EM Analysis of Adenovirus Vector Reveals Purification Conditions Leading to Loss of Viral Fiber Proteins and Reduced Infectivity

open access: yesBiotechnology and Bioengineering, EarlyView.
ABSTRACT Vaccines and gene therapies require efficient delivery of genetic material to host cells. Viral vectors leverage viruses' ability to enter host cells to achieve this. Following the SARS‐CoV‐2 vaccine and novel gene therapies that utilize adenovirus vectors, there has been an increase in the demand for large‐scale production of vectors.
Betsy Widdicombe   +7 more
wiley   +1 more source

Nuclease‐Free Scalable Purification of Physalis Mottle Virus‐Like Particles Expressed in Escherichia coli

open access: yesBiotechnology and Bioengineering, EarlyView.
ABSTRACT Plant virus‐like particles (VLPs) are promising nanotechnology platforms, but their translation requires purification strategies suitable for large‐scale production. Here, we developed a nuclease‐free downstream process for Physalis mottle virus (PhMV) VLPs expressed in Escherichia coli, combining ammonium sulfate precipitation, low‐pH ...
Sean K. Hsu   +3 more
wiley   +1 more source

Mapping programmable mRNA research relevant to cancer-associated immune escape: a dual-database bibliometric and topic modeling analysis. [PDF]

open access: yesFront Oncol
Zhou XJ   +12 more
europepmc   +1 more source

Tackling cancer stemness with nanotechnology in the era of precision medicine

open access: yesBMEMat, EarlyView.
Precise customization of nanoparticles (NPs) enables active targeting of cancer stem cells (CSCs), thereby improving drug delivery and therapeutic efficacy. NP‐based probing enhances CSC detection through imaging and liquid biopsy, whereas diverse therapeutic payloads improve therapeutic outcomes.
Shaolei Guo   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy